iOnctura’s Post

🌱 Embracing Renewal and Growth this Nowruz 🌱 As the first day of spring heralds the start of Persian New Year - Nowruz, it's a time to reflect on new beginnings and the promise of rejuvenation. At ThinkrBelle, Sigrun Watson and I embody the spirit of Nowruz year-round, nurturing fresh perspectives at the intersection of Pharma and Tech. In the same way that Nowruz represents a rebirth of nature, we at ThinkRBelle are dedicated to revitalizing healthcare. We stand as a bridge between the biopharmaceutical industry and the forward-thinking world of technology, sowing the seeds of innovation to bloom into solutions that enhance patient care and wellbeing. Our commitment mirrors the essence of Nowruz—celebrating life and the health of our communities. We cultivate a landscape where the fusion of pharma knowledge and tech ingenuity grows into a flourishing garden of therapeutic possibilities. As we welcome spring with open hearts, let's also open our minds to the transformative changes we can achieve together. Wishing everyone a Nowruz that's as inspiring and hopeful as the future we're building at ThinkRBelle. May this new season bring growth, health, and prosperity to all. #ThinkRBelle #HealthTech #PharmaTech #Innovation

We are excited to officially announce that Opyl has entered into a strategic partnership with Alithia Life Sciences, a leading CRO known for its advanced clinical research solutions! By bringing together Alithia’s expertise in clinical research and TrialKey’s AI-powered analytics, this partnership aims to elevate the quality and efficiency of clinical trial projects. TrialKey will provide Alithia with detailed reports that include probability of success predictions, optimised trial designs, and data validation to support their clinical trial planning. This collaboration allows us to address trial challenges head-on by offering data-backed recommendations on trial variables, competitor assessments, patient recruitment strategies, and site selection – all essential components for improving trial success rates. Investor enquiries: bernice@trialkey.ai Book a demo: https://appt.link/minhthu #clinicaltrials #clinicalresearch #aiinhealthcare #dataanalytics #partnership #innovation #biotech #healthcaretechnology

BIOVIIIx has been recognized as the Hemophilia Company of the Year In Europe by Life Sciences Review. BIOVIIIx is a family-run biotech firm that excels in haemophilia and rare diseases. Focusing on scientific research and global partnerships, it rapidly advances treatments and develops innovative solutions. The company invests in employee training, business modernisation and R&D, aiming for international growth through new business units and expanded therapeutic approaches "BIOVIIIx is grounded in ethical and human-centric values. Its decision-making process focuses on projects that directly benefit patients, often foregoing immediate financial gains. This patient-centric approach leads the company to go above and beyond standard practices." says Davide Rosiello, CEO The article will also be featured in the forthcoming special print edition of Hemophilia 2024. Read More : https://lnkd.in/gRB9nJiH #BiotechInnovation #ScientificResearch #HealthcareInnovation #InnovativeTherapies #PharmaResearch #EmployeeTraining

I look forward to sitting tomorrow fireside with Ed Tucker MD MBA at #CMO360 to chat about life sciences M&A, licensing and financing dynamics across the capital structure and royalties. Among other topics, we will explore what strategics are seeking with respect to collaboration partners (licensors). #M&A #Licensing #Biopharma

Did you know? Jarosław Kasprowicz, PhD, MBA, Head of Clinical Operations at Clinmark, who will be representing us at the upcoming Bio Convention in San Diego, boasts over 12 years of extensive expertise in clinical trials setup, monitoring, and management across diverse therapeutic fields. With his wealth of experience, he's ready to explore collaborations and discuss how Clinmark can elevate your research. Don't miss this opportunity to connect and schedule a meeting with him! #Clinmark #BioConvention #SanDiego #ClinicalResearch #CebioForum #PolishTradeandInvestmentAgncy

Making cell and gene therapies safely on a commercial scale is a challenge we must overcome to make these innovative treatments available to more people at a reasonable cost. CDMOs, or Commercial Drug Manufacturing Organizations, are an important part of the modern pharmaceutical supply chain for small molecules, biologics, and now CGTs. The Center for Breakthrough Medicines is one of the newest CGT CDMOs. Learn more about them in this interview from the Bullpen!

What an experience at the BIO International Convention in San Diego this past week. Our CEO, Zach Gobst, shared some powerful insights on why APAC is a prime destination for complex and challenging clinical trials.  One key insight: “Designing recruitment around engagement is crucial. In APAC, you can work with patients and physicians who prioritize your research, paired with a local staff model to navigate study nuances for high-quality results.” Tailoring our approach at the country and local level is a key element of Leapcure’s approach. It ensures better study outcomes and a deeper connection with the broader community. Let’s all continue to innovate and make a global impact. #clinicaltrials #APAC #patientengagement #BIO2024 #leapcure

🚨 Join Clinmark’s Round Table Discussion at the Fierce Clinical Summit! 🚨 We’re excited to invite all participants to our upcoming discussion, "STUDY SALVAGE: Understand When It's Time to Fire Your Clinical Partners and What Trial Rescue and Recovery Looks Like," on Thursday, September 26, 2024, from 4:45 PM to 5:30 PM EDT. 🌍 🗣️ What we’ll discuss: We meet to discuss an often-overlooked aspect—while everyone emphasizes collaboration, the reality is often quite different. We believe that creating a discussion around bad experiences is just as important as sharing the good ones, and it’s crucial to show that even in challenging situations, it doesn’t have to be the end of a trial. 🧠 Join us for this important, candid conversation about recognizing when it’s time to part ways with a clinical partner and what trial rescue and recovery can look like. 🤝 Don’t miss it, and stay tuned for more! #ClinicalTrials #StudySalvage #TrialRescue #IndustryInsights #Collaboration #ClinicalResearch #Transparency #TeamClinmark

Transitioning from research to clinical phase? Join our expert panel at #AusBiotech for pivotal insights to enhance your journey. Don't miss out—attend our session!

Transitioning from research to clinical phase? Join our expert panel at #AusBiotech for pivotal insights to enhance your journey. Don't miss out—attend our session!